Effect of age and sex on efficacy and tolerability of ? bloc
Effect of age and sex on efficacy and tolerability of ? blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis. Read more on @http://www.bmj.com/content/353/bmj.i1855
Effect of age and sex on efficacy and tolerability of ? blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis | The BMJ
Dipak Kotecha, clinician scientist in cardiovascular medicine1 2, Luis Manzano, professor of internal medicine3, Henry Krum, professor of medicine2, Giuseppe Rosano, professor of cardiology4 5, Jane Holmes, statistician 6, Douglas G Altman, professor of statistics in medicine6, Peter D Collins, professor of cardiology7, Milton Packer, distinguished scholar in cardiovascular science8, John Wikstrand, professor of clinical physiology9, Andrew J S Coats, professor and academic vice-president10 11, John G F Cleland, professor of clinical cardiology7, Paulus Kirchhof, professor of cardiovascular medicine1, Thomas G von Lueder, consultant cardiologist12, Alan S Rigby, reader and statistician13, Bert Andersson, professor of cardiology9, Gregory YH Lip, professor of cardiovascular medicine1, Dirk J van Veldhuisen, professor of cardiology14 , Marcelo C Shibata, associate clinical professor of medicine15, Hans Wedel, professor of epidemiology and biostatistics16, Michael Böhm, professor of internal medicine and cardiology17, Marcus D Flather, professor of medicine and clinical trials18 on behalf of the Beta-Blockers in Heart Failure Collaborative Group1University of Birmingham Institute of Cardiovascular Sciences, Birmingham, UK2Centre of Cardiovascular Research and Education in Therapeutics, Monash University, Melbourne, Australia3Internal Medicine Department, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, Madrid, Spain4Department of Medical Sciences, IRCCS San Raffaele Pisana, Roma, Italy5Cardiovascular and Cell Science Institute, St George’s University of London, London, UK6Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK7National Heart and Lung Institute, Imperial College, London, UK8Baylor University Medical Center, Dallas, USA9Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden10Monash Warwick Alliance, Monash University, Melbourne, Australia11Monash Warwick Alliance, University of Warwick, Warwick, UK12Department of Cardiology, Oslo University Hospital, Oslo, Norway13Academic Cardiology, Castle Hill Hospital, Kingston upon Hull, UK14Department of Cardiology, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands15Division of Cardiology, University of Alberta, Edmonton, Canada16Nordic School of Public Health, Gothenburg, Sweden17Universitätsklinikum des Saarlandes, Homburg/Saar, Germany18Norwich Medical School, University of East Anglia, Norwich, UKCorrespondence to: D Kotecha, University of Birmingham Institute of Cardiovascular Sciences, Medical School, Edgbaston, Birmingham B15 2TT, UK d.kotecha{at}bham.ac.ukAccepted 14 March 2016
Like
Comment
Share